The UC San Diego Rady School of Management today announced that Professor Ayelet Gneezy is the recipient of this year’s Robert B. Cialdini Award for excellence in a published field study.
Researchers at UC San Diego Health System’s Department of Reproductive Medicine and the National Latino Research Center (NLRC) at Cal State San Marcos University recently presented data at the American Public Health Association Conference in Washington D.C., demonstrating the impact of text4baby, a free mobile service that provides pregnant women and new mothers in San Diego with maternal, fetal and newborn health information via text messages and connects them to national health resources.
Dr. Chien and his colleagues have developed an array system (with thousands of combinations) that allows the rapid determination of the optimum physical and chemical conditions that direct the differentiation of stem cells into specific cell types. The ability to control stem cell differentiation to desired cell types is crucial for the use of human embryonic stem cells for regenerative medicine, and hence the results of this study will be valuable for almost all types of stem cell research.
Researchers at the University of California, San Diego School of Medicine and the UC San Diego Moores Cancer Center have identified a new drug discovery approach enabling the destruction of the most highly proliferative tumors. The discovery, published in the November 13 online issue of the journal Nature Medicine, points to an effective, alternative method for killing fast-growing cancer cells without causing some of the negative effects of current therapies.
Gordon, a unique data-intensive supercomputer using flash-based memory that will enter production in January at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, made its debut as the 48th fastest supercomputer in the world, according to the latest Top500 list.
By knocking out a key regulatory protein, scientists at the University of California, San Diego School of Medicine and the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland dramatically boosted insulin sensitivity in lab mice, an achievement that opens a new door for drug development and the treatment of diabetes.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
